How to compare representations with disclosure schedules for Share Purchase Transactions

Compare each representation in the share purchase agreement against its corresponding schedule, potentially relevant cross-disclosures, and underlying evidence. Preserve the representation’s entity scope, knowledge standard, materiality threshold, and measurement date before assessing the disclosure. The resulting buyer-side disclosure matrix should distinguish a sufficiently described exception from missing evidence, inconsistent facts, and unresolved contractual treatment. Use it to direct seller questions, proposed drafting, and buyer risk decisions—not merely to confirm that every schedule heading contains text.

When to use this workflow

Use this workflow when buyer counsel receives substantive disclosure schedules, a revised purchase agreement, or supplemental disclosures before signing or closing. It helps corporate, employment, tax, IP, and commercial reviewers coordinate findings against one negotiated set of representations.

The task is comparison, not replacement of diligence. Identify which selling holders, target entities, and subsidiaries each representation covers. Parent-level evidence may not answer a group-wide statement; target capitalization records may not establish each seller’s title.

This is a general US transactional workflow. Contractual effects depend on actual wording, governing law, facts, and deal context. The checks below are review recommendations, not statutory requirements. Treat seller disclosures as assertions to evaluate, not independently established facts.

What you need

Start with a controlled review packet:

• The current purchase agreement, including definitions, representation articles, disclosure conventions, closing conditions, and remedy provisions.
• Corresponding schedules, version dates, attachments, and incorporated lists.
• Prior matrix entries, seller responses, and unresolved specialist findings.
• A document index identifying entities, document IDs, execution status, versions, and data-room paths.
• Relevant capitalization and title records, contracts and amendments, consent correspondence, claims records, and IP ownership documents.
• Buyer priorities, escalation contacts, and authority to accept unresolved exposure.

Record what reviewers could actually access. An inaccessible attachment is missing evidence, not an affirmative statement that no exception exists.

Pair the schedule version with the agreement version. Renumbering, a revised Material Contract definition, or changed knowledge attribution can alter the comparison even when disclosure text remains unchanged.

Use the template

The Share Purchase Transactions — Representations disclosure matrix is a working comparison record. Copy this table into your working document or spreadsheet. Add rows for independently testable assertions rather than forcing an entire representation into one conclusion.

Use a stable row ID and clause reference in Row / rep, such as R-014 / §5.14(b). Record agreement and schedule versions above the table. Scope / qualifiers captures entities, knowledge attribution, materiality, and relevant dates.

Schedule / cross-ref identifies direct disclosures and proposed cross-disclosures. Evidence / pinpoint identifies the supporting document and clause or page—not merely its folder. In Gap / uncertainty, distinguish factual discrepancies from missing evidence and interpretation questions.

Use Buyer response for the requested evidence, clarification, drafting, or decision. Status / basis explains whether an issue is verified, unresolved, superseded, or accepted as risk. Acceptance does not mean the underlying fact was corrected.

Step by step

1. Fix the comparison baseline and disclosure rules

Record agreement and schedule versions, the review cutoff, and the acquisition perimeter. Read disclosure conventions before assessing individual entries. Identify any provisions addressing cross-disclosure, incorporation of data-room materials, and schedule supplements.

For example, §10.9 of the Booz Allen Hamilton–PAR agreement permits a disclosure to qualify another representation where its relevance is reasonably apparent on the disclosure’s face. This is agreement-specific wording, not a universal rule. (sec.gov)

As a review practice, separate the seller’s proposed disclosure route from the buyer’s assessment of its effectiveness.

Record: baseline details above the matrix and any disputed interpretation in a dedicated row assigned to counsel.

2. Break each representation into testable assertions

Separate assertions requiring different evidence. A material-contract representation might address list completeness, delivery of copies, defaults, and termination notices. A populated contract list cannot establish all four.

Preserve qualifiers in the analysis. Assess a knowledge-qualified statement about threatened claims against its actual knowledge definition, not an unqualified standard. Retain historical lookback periods and distinguish signing-date statements from representations tested again at closing.

For share ownership, separate issued shares, rights to acquire shares, seller title, liens, and transfer restrictions. Identify whether the seller, target, or both make the relevant statement.

Record: independently testable assertions with their entities, qualifiers, and dates visible before the reviewer’s conclusion.

3. Map direct and potentially relevant disclosures

Read the corresponding schedule, then examine related sections. A customer dispute may concern litigation, contract defaults, and receivables. An invention dispute may affect both employment and IP statements.

Identify the disclosure route without prematurely declaring it effective. Where the negotiated test concerns facial relevance, explain whether the disclosure itself connects to the other representation or requires outside information to establish that connection.

Distinguish “none,” a blank section, an omitted section, and a cross-reference. Ask the seller to resolve ambiguous presentation rather than supplying an assumed meaning.

Record: direct references, potential cross-disclosures, and requests for explicit disclosure against affected assertions.

4. Test disclosures against underlying evidence

Compare party names, entity coverage, dates, amounts, document completeness, and the stated status of each exception. Read amendments and side letters with the principal agreement. Test an assertion that a contract expired against renewal provisions and subsequent correspondence.

Section 5.14(b) of the Booz Allen Hamilton–PAR agreement separately represents that the buyer received or could access complete copies of written Material Contracts. It illustrates contractual wording, not proof of actual completeness; the agreement’s defined scope controls. (sec.gov)

Keep evidentiary availability separate from contractual disclosure. A located document may resolve what happened without resolving whether the representation is qualified.

Record: document IDs, pinpoints, observed facts, missing attachments, and discrepancies with the schedule description.

5. Formulate focused seller questions

Request answers capable of verification. Instead of “clarify consent issue,” identify the contract, ownership-change provision, schedule statement, and missing approval. Ask whether the seller’s position is that consent is unnecessary, obtained, or outstanding, and request its basis.

Access rights also require attention. Section 7.2(a) of the AMD–ZT Group agreement illustrates negotiated access limitations concerning third-party confidentiality, law, and privilege, alongside efforts obligations concerning consent or substitute access. It does not establish a general inspection entitlement. (sec.gov)

When access is constrained, request an appropriate alternative and refer privilege questions to responsible counsel rather than demanding unrestricted production.

Record: the precise question, response reference, owner, follow-up date, and evidence needed for resolution.

6. Decide the buyer’s contractual response

Make three separate assessments: Is the disclosure factually adequate? Does it qualify the representation under the agreement? Is the resulting exposure acceptable? Complete disclosure can still describe an unacceptable business risk.

Consider clearer disclosure, revised representations, specific covenants, consent deliverables, or negotiated risk allocation. Read related closing-condition and remedy provisions before proposing the response. If insurance forms part of the transaction structure, assign any coverage implications for separate review rather than assuming the policy answers the issue.

Prioritize by exposure and decision required. Identify the person authorized to approve a commercial concession.

Record: proposed treatment, reasoning, any authorized fallback, and decision-maker. Distinguish factual verification from risk acceptance.

7. Reconcile revisions and close the comparison

Recheck affected rows after changes to representations, definitions, disclosure conventions, or schedules. Removing a qualifier can expand the statement despite unchanged disclosure. Adding an exception can change the buyer’s decision without curing the underlying problem.

For supplements, examine the agreement’s treatment of timing, qualification, closing conditions, and remedies separately. Do not mark a row resolved merely because the seller delivered an updated schedule.

Preserve prior findings and link replacement evidence. Give specialist reviewers the changed text and affected row IDs so that their reassessment addresses the actual revision.

Record: final clause and schedule references, resolution evidence, approval, and remaining issues assigned for decision.

Worked example

Fictional scenario: Alder Quay Holdings proposes to acquire all shares of Meridian Sensor Systems. All parties, documents, and provisions below are fictional. Draft A-04 §5.14(c) states, without a knowledge qualifier, that no listed Material Contract requires consent because of the purchase. Section 5.14(b) addresses complete copies; §5.6 addresses outstanding share-acquisition rights. Each statement is measured at signing.

Schedule S-03 lists a customer contract but states that no consent is required. Its litigation section mentions a customer complaint without describing a consent issue. The fictional disclosure convention requires cross-disclosure relevance to be reasonably apparent on the disclosure’s face.

R-01 should not close merely because the contract was uploaded. The apparent conflict requires analysis of the defined ownership-change trigger, complete terms, and transaction structure. The complaint disclosure does not facially describe consent exposure; request explicit treatment if the seller intends it to qualify the consent representation.

R-02 creates an independent completeness question. Counsel cannot infer the unseen addendum’s contents or assume it leaves the consent provision unchanged. R-03 changes the inquiry from reading the schedule to reconciling equity records; approval alone proves neither issuance nor cancellation.

The buyer therefore needs targeted evidence and contractual decisions, not a general request to “update schedules.” Any complaint-related default issue should receive its own row rather than being treated as resolved by these three entries.

Common mistakes

• Treating schedule population as completion. Test each representation limb, including negative and completeness statements.
• Dropping qualifiers in summaries. Retain entity, knowledge, materiality, and temporal limits beside each conclusion.
• Equating upload with disclosure. Apply the negotiated disclosure rules and record accessibility separately.
• Accepting explanation as verification. Identify whether the seller supplied evidence, resolved interpretation, or merely stated a position.
• Treating an exception as a cure. Reassess exposure and obtain an authorized buyer decision before closing the row.

Final quality check

• Every substantive assertion has a row or explained grouping.
• Agreement and schedule versions match the baseline.
• Representing parties, entities, qualifiers, and dates remain accurate.
• Direct and proposed cross-disclosures have pinpoint references.
• Supporting documents and relevant amendments have been opened and checked.
• Missing evidence, contradictory evidence, and interpretation are distinguished.
• Resolved rows cite evidence; accepted risks identify the approver.
• Open issues have owners and defined evidence or decision requirements.

Complete the workflow with DecoverAI

DecoverAI is the Legal Intelligence Platform for litigation and transactions. For this workflow, use contract review with buyer-specific instructions; tabular review supports work across multiple documents, and due diligence classification can organize materials and prioritize human review. Keep the matrix as the legal team’s work product. Counsel must verify source text, assess disclosure sufficiency, and approve contractual responses. Book a demo to discuss this representations-and-schedules comparison workflow.

Frequently asked questions

Should every representation have a separate matrix row?

Account for every substantive assertion. Group assertions only when their qualifiers, disclosures, evidence, and resolution coincide. Split them when one issue can close independently of another.

Does a data-room document automatically qualify a representation?

Do not assume that result. Review the agreement’s incorporation and disclosure language. Keep two separate matrix conclusions: whether the document was available and whether the asserted contractual qualification is accepted or disputed.

What if one disclosure concerns several representations?

Map each affected assertion and assess the actual cross-disclosure test. Where the connection is unclear, request explicit references or fuller facts instead of treating reviewer inference as an agreed result.

How should late schedule changes be handled?

Preserve the earlier version, identify changed facts and affected rows, and assess the supplement’s proposed effect under the agreement. Reopen relevant buyer decisions and assign any remaining signing or closing issue expressly.

Sources

• Booz Allen Hamilton–PAR Stock Purchase Agreement, §§5.14(b) and 10.9: negotiated examples of copy completeness and cross-disclosure wording.
• AMD–ZT Group Stock Purchase Agreement, §7.2(a): negotiated example of qualified preclosing information access.

These filed agreements illustrate wording, not general law, market standards, or independently verified target facts.

This guide is general information about legal workflows, not legal advice for any matter. It was drafted and reviewed with AI assistance. The worked example is fictional. Contract rights and procedure depend on the governing law, the actual wording, and the facts, so check the cited sources and the rules that apply in your jurisdiction before relying on it.